151 related articles for article (PubMed ID: 23055731)
81. SiRNA drug delivery by biodegradable polymeric nanoparticles.
Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
[TBL] [Abstract][Full Text] [Related]
82. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
83. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
84. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
85. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
86. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept.
Chong RH; Gonzalez-Gonzalez E; Lara MF; Speaker TJ; Contag CH; Kaspar RL; Coulman SA; Hargest R; Birchall JC
J Control Release; 2013 Mar; 166(3):211-9. PubMed ID: 23313112
[TBL] [Abstract][Full Text] [Related]
87. Single siRNA nanocapsules for enhanced RNAi delivery.
Yan M; Liang M; Wen J; Liu Y; Lu Y; Chen IS
J Am Chem Soc; 2012 Aug; 134(33):13542-5. PubMed ID: 22866878
[TBL] [Abstract][Full Text] [Related]
88. Designing idiosyncratic hmPCL-siRNA nanoformulated capsules for silencing and cancer therapy.
Kumar VB; Medhi H; Yong Z; Paik P
Nanomedicine; 2016 Apr; 12(3):579-588. PubMed ID: 26554393
[TBL] [Abstract][Full Text] [Related]
89. Intracellular Co-delivery of native antibody and siRNA for combination therapy by using biodegradable silica nanocapsules.
Yuan P; Yang F; Liew SS; Yan J; Dong X; Wang J; Du S; Mao X; Gao L; Yao SQ
Biomaterials; 2022 Feb; 281():121376. PubMed ID: 35065331
[TBL] [Abstract][Full Text] [Related]
90. Simultaneous cytosolic delivery of a chemotherapeutic and siRNA using nanoparticle-stabilized nanocapsules.
Hardie J; Jiang Y; Tetrault ER; Ghazi PC; Tonga GY; Farkas ME; Rotello VM
Nanotechnology; 2016 Sep; 27(37):374001. PubMed ID: 27505356
[TBL] [Abstract][Full Text] [Related]
91. Optimization of Synthesis of the Amino Lipid ECO for Effective Delivery of Nucleic Acids.
Schilb AL; Scheidt JH; Vaidya AM; Sun Z; Sun D; Lee S; Lu ZR
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681240
[TBL] [Abstract][Full Text] [Related]
92. Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells.
Tang J; Li L; Howard CB; Mahler SM; Huang L; Xu ZP
J Mater Chem B; 2015 Sep; 3(33):6805-6812. PubMed ID: 27213045
[TBL] [Abstract][Full Text] [Related]
93. Artificial Base-Directed
Sun Y; Yu D; Geng X; Ding D; Yang Y; Liu Z; Xiao Z; Wang R; Tan W
ACS Appl Mater Interfaces; 2023 Feb; ():. PubMed ID: 36751121
[TBL] [Abstract][Full Text] [Related]
94. Supramolecular organization and biological interaction of squalenoyl siRNA nanoparticles.
Caillaud M; Gobeaux F; Hémadi M; Boutary S; Guenoun P; Desmaële D; Couvreur P; Wien F; Testard F; Massaad-Massade L
Int J Pharm; 2021 Nov; 609():121117. PubMed ID: 34562556
[TBL] [Abstract][Full Text] [Related]
95. Calcium phosphate nanoparticles-based systems for siRNA delivery.
Xu X; Li Z; Zhao X; Keen L; Kong X
Regen Biomater; 2016 Sep; 3(3):187-95. PubMed ID: 27252888
[TBL] [Abstract][Full Text] [Related]
96. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
Adv Mater; 2023 Apr; 35(16):e2300777. PubMed ID: 37078222
[No Abstract] [Full Text] [Related]
97. Impact of Lipid Composition on Vesicle Protein Adsorption: A BSA Case Study.
Amărandi RM; Neamṭu A; Ştiufiuc RI; Marin L; Drăgoi B
ACS Omega; 2024 Apr; 9(16):17903-17918. PubMed ID: 38680315
[TBL] [Abstract][Full Text] [Related]
98. RNAi in
Laisney J; Gurusamy D; Baddar ZE; Palli SR; Unrine JM
ACS Appl Mater Interfaces; 2020 Jun; 12(23):25645-25657. PubMed ID: 32412742
[TBL] [Abstract][Full Text] [Related]
99. Poly(ethylene glycol)-Based Peptidomimetic "PEGtide" of Oligo-Arginine Allows for Efficient siRNA Transfection and Gene Inhibition.
Hibbitts A; O'Connor AM; McCarthy J; Forde ÉB; Hessman G; O'Driscoll CM; Cryan SA; Devocelle M
ACS Omega; 2019 Jun; 4(6):10078-10088. PubMed ID: 31460100
[TBL] [Abstract][Full Text] [Related]
100. A health concern regarding the protein corona, aggregation and disaggregation.
Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
